Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 875 of 1467 entries
View as:

Dermacyd Femina (Lactic Acid) - Photo Dermatological Evaluation of the Irritation and Sensitivity Potential.

Phase: N/A Priority: Normal
NCT ID: NCT00705744 Org: User:
Start: 04/30/08 End: - Due: -

Dermacyd PH_DESILSTY_FR (Lactic Acid) - Acceptability - Stay on Frutal

Phase: N/A Priority: Normal
NCT ID: NCT00932945 Org: User:
Start: 06/30/09 End: 07/31/09 Due: 07/31/10

Treatment of Type 1 Diabetes With Anti-OX40L Bispecific With Anti-TNF Activity In a Single Nanobody® Molecule

Phase: N/A Priority: Normal
NCT ID: NCT06812988 Org: User:
Start: 02/28/25 End: 09/13/28 Due: 09/13/29

An Observational Study on Sarilumab-exposed Pregnancies

Phase: N/A Priority: Normal
NCT ID: NCT03378219 Org: User:
Start: 05/18/18 End: 12/06/24 Due: 12/06/25

Study of SAR97276A in the Treatment of Uncomplicated and Severe Malaria in Adults and Children.

Phase: N/A Priority: Normal
NCT ID: NCT00739206 Org: User:
Start: 08/31/08 End: 06/30/09 Due: 06/30/10

Awareness to Osteopenia's Treatment by Bisphosphonate in Male Suffering From Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00816452 Org: User:
Start: 01/31/09 End: 07/31/10 Due: 07/31/11

Dermacyd PH_DETINBACK (Lactic Acid) Sweet Flower - Compatibility

Phase: N/A Priority: Normal
NCT ID: NCT00785681 Org: User:
Start: 07/31/08 End: 09/30/08 Due: 09/30/09

Dose Escalation and Expansion Study of SAR444200-based Regimen in Adult Participants With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT05450562 Org: User:
Start: 09/20/22 End: 12/25/25 Due: 12/25/26

Study of Adacel® Vaccine Administered to Persons 10 Years of Age

Phase: N/A Priority: Normal
NCT ID: NCT01311557 Org: User:
Start: 03/31/11 End: 01/31/12 Due: 01/31/13

A Study to Assess the Safety and Efficacy of SAR425899 in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02973321 Org: User:
Start: 12/02/16 End: 12/27/17 Due: 12/27/18

Comparison of Two Treatment Regimens in Patients With Type 2 Diabetes After Short-term Intensive Insulin Therapy

Phase: N/A Priority: Normal
NCT ID: NCT03359837 Org: User:
Start: 01/20/18 End: 06/29/20 Due: 06/29/21

AMS VS MOXI Ketek vs Avelox in AMS

Phase: N/A Priority: Normal
NCT ID: NCT00537563 Org: User:
Start: 12/31/02 End: 09/30/03 Due: 09/30/04

Pharmacokinetic and Tolerability Study of 14 mg Single Dose of Teriflunomide in Subjects With Severe Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT01239459 Org: User:
Start: 11/30/10 End: 03/31/11 Due: 03/31/12

A Study Evaluating INIPARIB in Combination With Chemotherapy to Treat Triple Negative Breast Cancer Brain Metastasis

Phase: N/A Priority: Normal
NCT ID: NCT01173497 Org: User:
Start: 07/31/10 End: 07/31/13 Due: 07/31/14

Pharmacodynamic Effects of Lixisenatide Compared to Liraglutide in Patients With Type 2 Diabetes Not Adequately Controlled With Insulin Glargine With or Without Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01596504 Org: User:
Start: 05/31/12 End: 07/31/13 Due: 07/31/14

A Study Assessing Efficacy and Safety of SAR125844 in NSCLC Patients With MET Amplification

Phase: N/A Priority: Normal
NCT ID: NCT02435121 Org: User:
Start: 11/30/15 End: 01/31/16 Due: 01/31/17

ALBION "Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis"

Phase: N/A Priority: Normal
NCT ID: NCT00360386 Org: User:
Start: 03/31/04 End: 02/28/05 Due: 02/28/06

Efficacy and Safety of Dianicline Treatment as an Aid to Smoking Cessation in Cigarette Smokers (AMERIDIAN)

Phase: N/A Priority: Normal
NCT ID: NCT00387946 Org: User:
Start: 09/30/06 End: 09/30/07 Due: 09/30/08

A Study to Evaluate the Pharmacokinetic Profiles of Single 14 mg Teriflunomide Tablet in Healthy Chinese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02046629 Org: User:
Start: 05/31/14 End: 07/31/14 Due: 07/31/15

Dose-Ranging Study Evaluating AVE1625 in Abdominally Obese Patients With Atherogenic Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00345410 Org: User:
Start: 06/30/06 End: 06/30/07 Due: 06/30/08

Larotaxel Compared To Continuous Administration of 5-FU in Advanced Pancreatic Cancer Patients Previously Treated With A Gemcitabine-Containing Regimen

Phase: N/A Priority: Normal
NCT ID: NCT00417209 Org: User:
Start: 12/31/06 End: 11/30/09 Due: 11/30/10

A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous (SC) Administered Alirocumab in Healthy Chinese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02979015 Org: User:
Start: 11/29/16 End: 11/27/17 Due: 11/27/18

Retrospective Safety Survey In Patients Included In NV1FGF Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT01135797 Org: User:
Start: 06/30/10 End: 12/31/10 Due: 12/31/11

A Study to Investigate the Pharmacokinetics (PK), Tolerability and Safety of Two Different Dupilumab Drug Products in Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT05976373 Org: User:
Start: 01/05/15 End: 03/30/15 Due: 03/30/16

Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT05991323 Org: User:
Start: 12/12/23 End: 06/29/29 Due: 06/29/30